Nivolumab Trial Failure Raises the Question of Brain Imaging in Kidney Cancer
Nivolumab had limited efficacy against previously untreated brain metastases in patients with metastatic renal cell carcinoma, according to recent trial results.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Neurology | Renal Cell Carcinoma | Urology & Nephrology